Phosphorylated TDP-43 in Alzheimer’s disease and dementia with Lewy bodies
暂无分享,去创建一个
H. Akiyama | I. Mackenzie | M. Hasegawa | M. Onaya | T. Arai | K. Tsuchiya | S. Iritani | Takashi Nonoka | K. Niizato
[1] P. Mcgeer,et al. Colocalization of Transactivation-Responsive DNA-Binding Protein 43 and Huntingtin in Inclusions of Huntington Disease , 2008, Journal of neuropathology and experimental neurology.
[2] K. Sleegers,et al. Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease , 2008, Neurology.
[3] R. Petersen,et al. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia , 2008, Human molecular genetics.
[4] D. Dickson,et al. Ultrastructural localization of TDP-43 in filamentous neuronal inclusions in various neurodegenerative diseases , 2008, Acta Neuropathologica.
[5] William T. Hu,et al. Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease , 2008, Acta Neuropathologica.
[6] M. Morita,et al. Phosphorylated TDP‐43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis , 2008, Annals of neurology.
[7] J. Trojanowski,et al. Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. , 2008, The American journal of pathology.
[8] J. Trojanowski,et al. Concomitant TAR-DNA-Binding Protein 43 Pathology Is Present in Alzheimer Disease and Corticobasal Degeneration but Not in Other Tauopathies , 2008, Journal of neuropathology and experimental neurology.
[9] C. Jack,et al. Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype , 2008, Neurology.
[10] B. McConkey,et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis , 2008, Nature Genetics.
[11] Murray Grossman,et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis , 2008, The Lancet Neurology.
[12] J. Morris,et al. TDP‐43 A315T mutation in familial motor neuron disease , 2008, Annals of neurology.
[13] A. Kakita,et al. TDP‐43 mutation in familial amyotrophic lateral sclerosis , 2008, Annals of neurology.
[14] Xun Hu,et al. TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.
[15] J. Growdon,et al. TAR-DNA Binding Protein 43 in Pick Disease , 2008, Journal of neuropathology and experimental neurology.
[16] H. Arai,et al. Concurrence of TDP-43, tau and α-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies , 2007, Brain Research.
[17] J. Trojanowski,et al. TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: protein misfolding diseases without amyloidosis. , 2007, Archives of neurology.
[18] K. Sleegers,et al. Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family. , 2007, Archives of neurology.
[19] John L. Robinson,et al. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases , 2007, Acta Neuropathologica.
[20] J. Morris,et al. TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. , 2007, The American journal of pathology.
[21] H. Arai,et al. Appearance pattern of TDP-43 in Japanese frontotemporal lobar degeneration with ubiquitin-positive inclusions , 2007, Neuroscience Letters.
[22] D. Dickson,et al. TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease , 2007, Annals of neurology.
[23] J. Trojanowski,et al. Pathological TDP‐43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations , 2007, Annals of neurology.
[24] G. Schellenberg,et al. A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology. , 2007, Brain : a journal of neurology.
[25] H. Akiyama,et al. TDP-43 is deposited in the Guam parkinsonism-dementia complex brains. , 2007, Brain : a journal of neurology.
[26] A. Kakita,et al. TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation , 2007, Acta Neuropathologica.
[27] D. Neary,et al. Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43 , 2007, Acta Neuropathologica.
[28] H. Akiyama,et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. , 2006, Biochemical and biophysical research communications.
[29] H. Feldman,et al. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. , 2006, Brain : a journal of neurology.
[30] Bruce L. Miller,et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.
[31] J. Trojanowski,et al. Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. , 2006, The American journal of pathology.
[32] Julie S. Snowden,et al. Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype , 2006, Acta Neuropathologica.
[33] J. Morris,et al. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin‐positive, tau‐negative inclusions caused by a missense mutation in the signal peptide of progranulin , 2006, Annals of neurology.
[34] C. Duijn,et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 , 2006, Nature.
[35] S. Melquist,et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 , 2006, Nature.
[36] F. Baas,et al. Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3. , 2006, Brain : a journal of neurology.
[37] H. Horvitz,et al. A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia , 2006, Neurology.
[38] S Minoshima,et al. Diagnosis and management of dementia with Lewy bodies , 2005, Neurology.
[39] A. Pestronk,et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein , 2004, Nature Genetics.
[40] K. Kosaka,et al. Diffuse lewy body disease in Japan , 1990, Journal of Neurology.
[41] A. Levy,et al. A Canadian Cohort Study of Cognitive Impairment and Related Dementias (ACCORD): Study Methods and Baseline Results , 2003, Neuroepidemiology.
[42] H. Akiyama,et al. Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration , 2003, Acta Neuropathologica.
[43] J. Growdon,et al. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. , 1999, Journal of neuropathology and experimental neurology.